Co-Dx is a company that develops and provides molecular diagnostic solutions, primarily focusing on real-time PCR (Polymerase Chain Reaction) testing. The company offers a range of products, including the Co-Dx Box, a compact and portable qPCR cycler, and various test kits for detecting infectious diseases such as COVID-19, influenza, tuberculosis, and mosquito-borne illnesses. Co-Dx's products cater to different markets, including at-home testing, healthcare professionals, laboratories, and vector control professionals. The company's proprietary Co-Primers technology enables accurate and reliable PCR testing, and its solutions are designed to be user-friendly, cost-effective, and compatible with most qPCR equipment. Co-Dx provides both in vitro diagnostic (IVD) products, which are regulated and approved for clinical use, and research use only (RUO) products for non-clinical applications.

At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to those regions where pricing is paramount. Because we own our platform, we are able to accomplish this faster and more economically, allowing for wider margins while still positioning Co-Diagnostics to be the worldwide low-cost leader of molecular diagnostics services.

PRODUCTS
Co-Diagnostics offers a range of products and services to suit the needs of diagnostics laboratories, research institutions, and enterprises across the globe that rely on PCR technology.

APPLICATIONS
Co-Diagnostics was founded with a simple but ambitious goal: to bring high-quality molecular diagnostics for infectious diseases to areas and populations of the world that need them most. Since that time, Co-Diagnostics researchers have developed additional applications far beyond the detection of infectious diseases.

TECHNOLOGY
Co-Diagnostics owns all the technology on which its products are designed. We use unique, cutting-edge and patent-protected products for the molecular diagnostics market, which allows for more affordable testing, research, and design solutions. Learn more about our patented CoPrimers™, and the performance and cost-saving advantages of the Co-Diagnostics platform.

13485:2016, FDA, CE-IVD

Co-Diagnostics offers a range of products and services to suit the needs of diagnostics laboratories, research institutions, and enterprises across the globe that rely on PCR technology. All Co-Diagnostics Diagnostic Solutions have passed our own extensive internal validation assessments to ensure they meet our goal of producing high-quality diagnostics that exceed customer expectations, and are only available as in-vitro diagnostics (IVDs) where they are in compliance with the registration and regulatory requirements of importing countries, including approvals by the appropriate regulatory bodies as necessary.
https://codiagnostics.com/products/diagnostic-solutions/

2013